During the past decade, The North Texas Research Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The North Texas Research Institute" #1 sponsor was "Gilead Sciences" with 7 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Alexion" with 1 trials sponsored, "Debiopharm International SA" with 1 trials sponsored and "FibroGen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The North Texas Research Institute" #1 collaborator was "Astellas Pharma Europe B.V." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The North Texas Research Institute" are "Hepatitis C, Chronic" (4 trials), "Hepatitis C Virus" (3 trials), "Hepatitis C" (2 trials), "CKD Anemia in Stable Dialysis Patients" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "The North Texas Research Institute" in a lesser frequency.

Most popular intervention types in "The North Texas Research Institute" are "Drug" (14 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ribavirin" (3 trials), "ribavirin" (3 trials), "Copegus®" (2 trials) and "Daclatasvir" (2 trials). Other intervention names were less common.

The vast majority of trials in "The North Texas Research Institute" are 15 trials for "All" genders.

Currently, there are NaN active trials in "The North Texas Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in The North Texas Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The North Texas Research Institute, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".